Latest Strategic Partnership News

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

Macro Metals Limited and WA Limestone have completed the acquisition of the Derby East Construction Sands Project near Derby, WA, positioning themselves to tap into growing Southeast Asian sand markets. The project offers low-risk mining potential with strong logistics links to the Port of Derby.

Aeris Resources has unveiled its FY26 guidance, forecasting a significant 37% increase in copper production at its Tritton operation alongside strategic divestments and a robust exploration agenda.

AnteoTech has signed a binding Term Sheet with US-based Black Diamond Structures to jointly develop and commercialise an advanced battery additive combining their proprietary technologies, targeting improved lithium-ion battery anodes with higher silicon content.

Amaero Ltd reports solid June quarter revenue and signs a pivotal five-year exclusive supply agreement with Velo3D, underpinning its growth outlook and updated EBITDA guidance for FY2027.

Tivan Limited and Sumitomo Corporation have signed a Memorandum of Understanding to jointly develop the high-grade Sandover Fluorite Project in Australia's Northern Territory, marking a significant step in Australia's critical minerals sector.

Tivan and Sumitomo Corporation have formalised their joint venture for the Speewah Fluorite Project, securing a strategic investment from Japan’s JOGMEC. This partnership marks a significant step towards advancing the project’s feasibility and strengthening Australia-Japan critical minerals ties.

Cleo Diagnostics reports steady progress in its ovarian cancer diagnostic test development, with clinical trial recruitment on track and strategic access to major biobanks enhancing its regulatory pathway.

PainChek has completed its final FDA submission for the PainChek Adult App, targeting the US long-term care market with a potential $100 million annual opportunity. A regulatory decision is expected within 75 days, setting the stage for rapid commercialisation.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Aura Energy has marked significant progress toward uranium production at its Tiris project in Mauritania, while forging a key collaboration to advance uranium exploration in Sweden amid shifting regulatory landscapes.